{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:19:35Z","timestamp":1790039975223,"version":"4.0.1"},"reference-count":46,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Black children with acute lymphoblastic leukemia (ALL) have poor outcomes, but limited information is available for children from other racial and ethnic backgrounds, such as Hispanic and Asian. We undertook a retrospective cohort study of children with ALL treated on Children's Cancer Group therapeutic protocols to determine outcomes by racial and ethnic backgrounds of patients treated with contemporary risk-based therapy. In total, 8447 children (white, n\u2009=\u20096703; Hispanic, n\u2009=\u20091071; black, n\u2009=\u2009506; and Asian, n\u2009=\u2009167) with newly diagnosed ALL between 1983 and 1995 were observed for a median of 6.5 years. Analysis of disease outcome was measured as overall survival (OS) and event-free survival (EFS) and was adjusted for known predictors of outcome including clinical features, disease biology, socioeconomic status, and treatment era (1983-1989 vs 1989-1995). There was a statistically significant difference in survival by ethnicity (P\u2009&lt;\u2009.001). Five-year EFS rates were: Asian, 75.1%\u2009\u00b1\u20093.5%; white, 72.8%\u2009\u00b1\u20090.6%; Hispanic, 65.9%\u2009\u00b1\u20091.5%; and black, 61.5%\u2009\u00b1\u20092.2%. Multivariate analysis revealed that when compared with white children, black and Hispanic children had worse outcomes and Asian children had better outcomes after adjusting for known risk factors. The poorer outcomes among black children were most apparent among patients with standard-risk features (relative risk [RR], 2.0; 95% confidence interval [CI], 1.6-2.5), whereas poorer outcomes in Hispanic children (RR, 1.4; 95% CI, 1.2-1.6) were most evident among patients with high-risk features. Asian children had better outcomes than all racial and ethnic groups among high-risk patients, particularly in the recent era (5-year EFS, 90.9%\u2009\u00b1\u20096.1%). Racial and ethnic differences in OS and EFS persist among children with ALL who receive contemporary risk-based therapy. Future studies should focus on reasons\u2014perhaps compliance or pharmacogenetics\u2014for those differences.<\/jats:p>","DOI":"10.1182\/blood-2002-02-0395","type":"journal-article","created":{"date-parts":[[2002,8,28]],"date-time":"2002-08-28T18:22:57Z","timestamp":1030558977000},"page":"1957-1964","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":227,"title":["Racial and ethnic differences in survival of children with acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"100","author":[{"given":"Smita","family":"Bhatia","sequence":"first","affiliation":[{"name":"From the City of Hope National Medical Center, Duarte, CA; Keck School of Medicine, University of Southern California, Los Angeles; The Ohio State University, Columbus; Alfred I Dupont Hospital for Children, Wilmington, DE; Children's Hospital, Los Angeles, CA; and University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harland N.","family":"Sather","sequence":"additional","affiliation":[{"name":"From the City of Hope National Medical Center, Duarte, CA; Keck School of Medicine, University of Southern California, Los Angeles; The Ohio State University, Columbus; Alfred I Dupont Hospital for Children, Wilmington, DE; Children's Hospital, Los Angeles, CA; and University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyla A.","family":"Heerema","sequence":"additional","affiliation":[{"name":"From the City of Hope National Medical Center, Duarte, CA; Keck School of Medicine, University of Southern California, Los Angeles; The Ohio State University, Columbus; Alfred I Dupont Hospital for Children, Wilmington, DE; Children's Hospital, Los Angeles, CA; and University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Trigg","sequence":"additional","affiliation":[{"name":"From the City of Hope National Medical Center, Duarte, CA; Keck School of Medicine, University of Southern California, Los Angeles; The Ohio State University, Columbus; Alfred I Dupont Hospital for Children, Wilmington, DE; Children's Hospital, Los Angeles, CA; and University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Gaynon","sequence":"additional","affiliation":[{"name":"From the City of Hope National Medical Center, Duarte, CA; Keck School of Medicine, University of Southern California, Los Angeles; The Ohio State University, Columbus; Alfred I Dupont Hospital for Children, Wilmington, DE; Children's Hospital, Los Angeles, CA; and University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L.","family":"Robison","sequence":"additional","affiliation":[{"name":"From the City of Hope National Medical Center, Duarte, CA; Keck School of Medicine, University of Southern California, Los Angeles; The Ohio State University, Columbus; Alfred I Dupont Hospital for Children, Wilmington, DE; Children's Hospital, Los Angeles, CA; and University of Minnesota, Minneapolis."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111619573181200_B1","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F","article-title":"Incidence of cancer in children in the United States: sex-, race- and 1-year age-specific rates by histologic type.","volume":"75","author":"Gurney","year":"1995","journal-title":"Cancer."},{"key":"2019111619573181200_B2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia.","volume":"339","author":"Pui","year":"1998","journal-title":"N Engl J Med."},{"key":"2019111619573181200_B3","volume-title":"Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program.","author":"Ries","year":"1999"},{"key":"2019111619573181200_B4","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/1097-0142(19910415)67:8<2125::AID-CNCR2820670820>3.0.CO;2-A","article-title":"Survival of children and adolescents with acute lymphoid leukemia: a study of American Indians and Hispanics and non-Hispanic whites treated in New Mexico (1969 to 1986).","volume":"67","author":"Foucar","year":"1991","journal-title":"Cancer."},{"key":"2019111619573181200_B5","first-page":"146","article-title":"Ethnicity and survival in children with acute lymphoid leukemia.","volume":"7(suppl 2)","author":"Pinkel","year":"1993","journal-title":"Leukemia."},{"key":"2019111619573181200_B6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<563::AID-CNCR20>3.0.CO;2-1","article-title":"Ethnicity and cure rates of Texas children with acute lymphoid leukemia.","volume":"77","author":"Hord","year":"1996","journal-title":"Cancer."},{"key":"2019111619573181200_B7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/1097-0142(197201)29:1<210::AID-CNCR2820290131>3.0.CO;2-U","article-title":"Poor prognosis in Negro children with acute lymphocytic leukemia.","volume":"29","author":"Walters","year":"1972","journal-title":"Cancer."},{"key":"2019111619573181200_B8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mpo.2950230606","article-title":"U.S. childhood cancer survival, 1973-1987.","volume":"23","author":"Novakovic","year":"1994","journal-title":"Med Pediatr Oncol."},{"key":"2019111619573181200_B9","first-page":"163","article-title":"Racial variation in the frequency of immunological subtypes of childhood acute lymphoblastic leukemia.","volume":"27","author":"Reaman","year":"1984","journal-title":"Prog Cancer Res Ther."},{"key":"2019111619573181200_B10","first-page":"179","article-title":"Differences in the presentation of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in black children and white children: a report from the Epidemiology Committee of the Children's Cancer Study Group.","volume-title":"Pathogenesis of Leukemias and Lymphomas: Environmental Influences.","author":"Sather","year":"1984"},{"key":"2019111619573181200_B11","first-page":"191","article-title":"Clinical and phenotypic features of childhood acute lymphocytic leukemia in whites, blacks, and Hispanics: a Pediatric Oncology Group study.","volume":"27","author":"Falletta","year":"1984","journal-title":"Prog Cancer Res Ther."},{"key":"2019111619573181200_B12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0145-2126(85)90300-5","article-title":"Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukemia: implications for treatment outcome.","volume":"9","author":"Kalwinsky","year":"1985","journal-title":"Leuk Res."},{"key":"2019111619573181200_B13","volume-title":"SEER Cancer Statistics Review, 1973-1996.","author":"Ries","year":"1999"},{"key":"2019111619573181200_B14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.1995.03520320043039","article-title":"Outcome of treatment for childhood cancer in black as compared with white children: the St. Jude Children's Research Hospital experience 1962 through 1992.","volume":"273","author":"Pui","year":"1995","journal-title":"JAMA."},{"key":"2019111619573181200_B15","first-page":"668","article-title":"Should therapy be intensified for patients with good risk ALL [abstract]?","volume":"88","author":"Hutchinson","year":"1996","journal-title":"Blood."},{"key":"2019111619573181200_B16","first-page":"559","article-title":"Double delayed intensification improves outcome in moderate risk pediatric acute lymphoblastic leukemia (ALL): a Children's Cancer Group study, CCG-1891 [abstract].","volume":"90","author":"Lange","year":"1997","journal-title":"Blood."},{"key":"2019111619573181200_B17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428199609045714","article-title":"Improved outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group study.","volume":"24","author":"Uckun","year":"1996","journal-title":"Leuk Lymphoma."},{"key":"2019111619573181200_B18","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1200\/JCO.1997.15.6.2214","article-title":"Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.","volume":"15","author":"Uckun","year":"1997","journal-title":"J Clin Oncol."},{"key":"2019111619573181200_B19","first-page":"735","article-title":"Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.","volume":"91","author":"Uckun","year":"1998","journal-title":"Blood."},{"key":"2019111619573181200_B20","first-page":"527","article-title":"Dexamethasone (DEX) decreases central nervous system (CNS) relapse and improves event-free survival (EFS) in lower risk acute lymphoblastic leukemia (ALL) [abstract].","volume":"17","author":"Bostrom","year":"1998","journal-title":"Proc Am Soc Clin Oncol."},{"key":"2019111619573181200_B21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1200\/JCO.1999.17.2.445","article-title":"Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.","volume":"17","author":"Reaman","year":"1999","journal-title":"J Clin Oncol."},{"key":"2019111619573181200_B22","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","article-title":"Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.","volume":"338","author":"Nachman","year":"1998","journal-title":"N Engl J Med."},{"key":"2019111619573181200_B23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1200\/JCO.1998.16.3.920","article-title":"Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.","volume":"16","author":"Nachman","year":"1998","journal-title":"J Clin Oncol."},{"key":"2019111619573181200_B24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<600::AID-CNCR24>3.0.CO;2-4","article-title":"Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.","volume":"82","author":"Steinherz","year":"1998","journal-title":"Cancer."},{"key":"2019111619573181200_B25","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1200\/JCO.1997.15.6.2222","article-title":"Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.","volume":"15","author":"Nachman","year":"1997","journal-title":"J Clin Oncol."},{"key":"2019111619573181200_B26","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jnci\/91.20.1765","article-title":"Breast-feeding and risk of childhood acute leukemia.","volume":"91","author":"Shu","year":"1999","journal-title":"J Natl Cancer Inst."},{"key":"2019111619573181200_B27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"2019111619573181200_B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples.","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer."},{"key":"2019111619573181200_B29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling Survival Data in Medical Research.","author":"Collett","year":"1994"},{"key":"2019111619573181200_B30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","article-title":"Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.","volume":"14","author":"Smith","year":"1996","journal-title":"J Clin Oncol"},{"key":"2019111619573181200_B31","volume-title":"Methods in Observational Epidemiology: Retrospective Cohort Studies.","author":"Kelsey","year":"1986"},{"key":"2019111619573181200_B32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1200\/JCO.2000.18.4.813","article-title":"Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group study.","volume":"18","author":"Pollock","year":"2000","journal-title":"J Clin Oncol."},{"key":"2019111619573181200_B33","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199310283291801","article-title":"Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital.","volume":"329","author":"Rivera","year":"1993","journal-title":"N Engl J Med."},{"key":"2019111619573181200_B34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood.V65.5.1079.1079","article-title":"Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia.","volume":"65","author":"Look","year":"1985","journal-title":"Blood."},{"key":"2019111619573181200_B35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood.V68.1.205.bloodjournal681205","article-title":"Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia.","volume":"68","author":"Williams","year":"1986","journal-title":"Blood."},{"key":"2019111619573181200_B36","first-page":"4036","article-title":"Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood."},{"key":"2019111619573181200_B37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1998.16.2.527","article-title":"Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.","volume":"16","author":"Uckun","year":"1998","journal-title":"J Clin Oncol."},{"key":"2019111619573181200_B38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0022-3476(05)83125-7","article-title":"Biology and treatment of acute lymphoblastic leukemia.","volume":"124","author":"Pui","year":"1994","journal-title":"J Pediatr."},{"key":"2019111619573181200_B39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJM199307083290207","article-title":"The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986.","volume":"324","author":"Pappas","year":"1993","journal-title":"N Engl J Med."},{"key":"2019111619573181200_B40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM199007053230104","article-title":"Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.","volume":"323","author":"Koren","year":"1990","journal-title":"N Engl J Med."},{"key":"2019111619573181200_B41","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3476(87)80131-2","article-title":"Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia.","volume":"111","author":"Garre","year":"1987","journal-title":"J Pediatr."},{"key":"2019111619573181200_B42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","article-title":"Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia.","volume":"336","author":"Lennard","year":"1990","journal-title":"Lancet."},{"key":"2019111619573181200_B43","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V93.9.2817","article-title":"Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.","volume":"93","author":"Relling","year":"1999","journal-title":"Blood."},{"key":"2019111619573181200_B44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","article-title":"The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations.","volume":"9","author":"Collie-Duguid","year":"1999","journal-title":"Pharmacogenetics."},{"key":"2019111619573181200_B45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/hmg\/8.2.371","article-title":"Polymorphism of the thiopurine S-methyltransferase gene in blacks.","volume":"8","author":"Hon","year":"1999","journal-title":"Hum Mol Genet."},{"key":"2019111619573181200_B46","first-page":"289","article-title":"Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk; mutations in brief no. 191.","volume":"12","author":"Walker","year":"1998","journal-title":"Hum Mutat."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/6\/1957\/1256206\/h81802001957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/6\/1957\/1256206\/h81802001957.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T00:57:53Z","timestamp":1573952273000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/6\/1957\/16564\/Racial-and-ethnic-differences-in-survival-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9,15]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-02-0395","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9,15]]}}}